Welcome to LookChem.com Sign In|Join Free

CAS

  • or

364-62-5

Post Buying Request

364-62-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

364-62-5 Usage

Uses

Different sources of media describe the Uses of 364-62-5 differently. You can refer to the following data:
1. Metoclopramide is a treatment of choice of post-operative nausea and vomiting (PONV) prophylaxis.
2. antidiabetic

Originator

Primperan,Delagrange,France,1964

Definition

ChEBI: A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Manufacturing Process

The N-(diethylaminoethyl)-2-methoxy-4-aminobenzamide used as the starting material may be prepared from o-toluidine. The o-toluidine is initially nitrated with nitric acid to produce 4-nitro-o-toluidine. The 4-nitro-o-toluidine is then converted to 2-hydroxy-4-nitrotoluene by heating with nitrous acid. By reacting the resulting 2-hydroxy-4-nitrotoluene with dimethyl sulfate, 2- methoxy-4-nitrotoluene is formed. The 2-methoxy-4-nitrotoluene is oxidized with potassium permanganate to produce 2-methoxy-4-nitrobenzoic acid. The latter substituted benzoic acid is treated with thionyl chloride to form 2- methoxy-4-nitrobenzoyl chloride. A methyl ethyl ketone solution of the 2- methoxy-4-nitrobenzoyl chloride is added over a period of about 1? hours to a methyl ethyl ketone solution containing an equal molecular quantity of N,Ndiethylethylene diamine while stirring and maintaining the temperature between 0°C and 5°C. The N-(diethylaminoethyl)-2-methoxy-4- nitrobenzamide hydrochloride formed precipitates. It is filtered, washed twice with methyl ethyl ketone, dissolved in alcohol, and reduced catalytically in an absolute isopropyl alcohol solution to form N-(diethylaminoethyl)-2-methoxy- 4-aminobenzamide. The base is obtained by precipitating with sodium hydroxide.80 g (0.3mol) of N-(2-diethylaminoethyl)-2-methoxy-4-aminobenzamide are dissolved in small portions in 150 cc of acetic acid. The mixture is cooled and 45 g (0.45 mol) of acetic anhydride are added, and the solution obtained is heated for two hours on a water bath. After cooling, the solution is decanted into a round-bottomed flask with a stirrer, a thermometer and a tube for introducing the chlorine. It is stirred and the current of chlorine is passed through, the temperature being maintained between 20°C and 25°C. The stirring is continued for one hour after the completion of the absorption of the chlorine.The mixture obtained is poured into 2 liters of water and the base is precipitated with 30% soda. The precipitated base is extracted with 400 cc of methylene chloride. After evaporation of the solvent, the N-(2- diethylaminoethyl)-2-methoxy-4-acetamino-5-chlorobenzamide formed crystallizes. The melting point is 86°C to 87°C and the yield is 95%.To obtain the corresponding amino derivative, 109 g of base are heated under agitation in a round-bottomed flask with 300 cc of 35-36% concentrated hydrochloric acid and 600 cc of water. It is heated on a water bath until dissolution is complete, then maintained at boiling point for 90 minutes, cooled, diluted with 1 liter of water, and neutralized with about 350 cc of 30% soda. The N-(2-diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide formed crystallizes, is centrifuged and washed in water. Its melting point is 122°C and the yield is 74%.To obtain the corresponding dihydrochloride, the base is dissolved in absolute alcohol (3 volumes) and to that solution is added 5 N alcoholic hydrochloric acid. The dihydrochloride precipitates, is centrifuged and washed with alcohol. It is a solid white material, having a melting point of 134°C to 135°C.

Brand name

Maxolon (King); Reglan (Baxter Healthcare); Reglan (Robins); Reglan (Schwarz Pharma).

Therapeutic Function

Antiemetic

General Description

Metoclopramide is typically employed as an antiemetic drug or a gastrointestinal prokinetic drug in adults and children.

Check Digit Verification of cas no

The CAS Registry Mumber 364-62-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,6 and 4 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 364-62:
(5*3)+(4*6)+(3*4)+(2*6)+(1*2)=65
65 % 10 = 5
So 364-62-5 is a valid CAS Registry Number.
InChI:InChI=1/C14H22ClN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19)

364-62-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (M2218)  Metoclopramide  >98.0%(GC)(T)

  • 364-62-5

  • 5g

  • 340.00CNY

  • Detail
  • TCI America

  • (M2218)  Metoclopramide  >98.0%(GC)(T)

  • 364-62-5

  • 25g

  • 990.00CNY

  • Detail
  • Sigma-Aldrich

  • (M1824990)  Metoclopramide  European Pharmacopoeia (EP) Reference Standard

  • 364-62-5

  • M1824990

  • 1,880.19CNY

  • Detail
  • Sigma-Aldrich

  • (32473)  Metoclopramide  VETRANAL, analytical standard

  • 364-62-5

  • 32473-100MG

  • 1,195.74CNY

  • Detail

364-62-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name metoclopramide

1.2 Other means of identification

Product number -
Other names 4-Amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:364-62-5 SDS

364-62-5Synthetic route

4-amino-5-chloro-2-methoxybenzoic acid
7206-70-4

4-amino-5-chloro-2-methoxybenzoic acid

N,N-diethylethylenediamine
100-36-7

N,N-diethylethylenediamine

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
With borane-ammonia complex In 5,5-dimethyl-1,3-cyclohexadiene for 6h; Reflux;88%
reglan
7232-21-5

reglan

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
With sodium hydrogencarbonate In methanol; dichloromethane65%
methyl 2-methoxy 4-acetamido 5-chloro benzoate
4093-31-6

methyl 2-methoxy 4-acetamido 5-chloro benzoate

N,N-diethylethylenediamine
100-36-7

N,N-diethylethylenediamine

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
With sodium hydroxide; acetic acid 1.) 90-95 deg C, 4 h, 2.) water, heating; Yield given. Multistep reaction;
C11H12ClNO5
150007-96-8

C11H12ClNO5

N,N-diethylethylenediamine
100-36-7

N,N-diethylethylenediamine

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
In tetrahydrofuran for 3h; Ambient temperature; Yield given;
4-amino-5-chloro-2-methoxybenzoic acid
7206-70-4

4-amino-5-chloro-2-methoxybenzoic acid

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine / tetrahydrofuran / 1 h / 0 °C
2: tetrahydrofuran / 3 h / Ambient temperature
View Scheme
Methyl 4-amino-2-methoxybenzoate
27492-84-8

Methyl 4-amino-2-methoxybenzoate

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: H2O / 1.) room temp., 30 min., 2.) 60-70 deg C, 1 h
2: aq. sodium hypochlorite / 1 h
3: 1.) glacial acetic acid, 2.) NaOH / 1.) 90-95 deg C, 4 h, 2.) water, heating
View Scheme
methyl 4-(acetylamino)-o-anisate
4093-29-2

methyl 4-(acetylamino)-o-anisate

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq. sodium hypochlorite / 1 h
2: 1.) glacial acetic acid, 2.) NaOH / 1.) 90-95 deg C, 4 h, 2.) water, heating
View Scheme
4-amino-5-chloro-2-methoxybenzoic acid
7206-70-4

4-amino-5-chloro-2-methoxybenzoic acid

N,N-diethylethylenediamine
100-36-7

N,N-diethylethylenediamine

1-methanesulfonyloxy-1,2,3-benzotriazole
54769-22-1

1-methanesulfonyloxy-1,2,3-benzotriazole

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
With sodium hydroxide; triethylamine In chloroform; water
C17H27ClN4O2
89881-28-7

C17H27ClN4O2

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
Stage #1: C17H27ClN4O2 With ethylenediamine In ethanol for 10h; Reflux;
Stage #2: With water
2.32 g
carbon monoxide
201230-82-2

carbon monoxide

2-chloro-4-iodo-5-methoxyaniline
1285695-15-9

2-chloro-4-iodo-5-methoxyaniline

N,N-diethylethylenediamine
100-36-7

N,N-diethylethylenediamine

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
With triethylamine; triphenylphosphine; bis(dibenzylideneacetone)-palladium(0) In 1,4-dioxane at 80℃; Inert atmosphere; Sealed chamber;63.2 mg
2-chloro-5-methoxyaniline
2401-24-3

2-chloro-5-methoxyaniline

metoclopramide
364-62-5

metoclopramide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: ethyl acetate
2: triethylamine; triphenylphosphine; bis(dibenzylideneacetone)-palladium(0) / 1,4-dioxane / 80 °C / Inert atmosphere; Sealed chamber
View Scheme
metoclopramide
364-62-5

metoclopramide

4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-hydroxybenzamide
38339-95-6

4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-hydroxybenzamide

Conditions
ConditionsYield
With sodium hydride; ethanethiol In N,N-dimethyl-formamide at 100 - 105℃; for 1.5h;98%
NH4(1+)*Cr(3+)*4NSC(1-)*2NH2C6H5 = NH4[Cr(NCS)4(NH2C6H5)2]

NH4(1+)*Cr(3+)*4NSC(1-)*2NH2C6H5 = NH4[Cr(NCS)4(NH2C6H5)2]

metoclopramide
364-62-5

metoclopramide

4CNS(1-)*Cr(3+)*2C6H7N*C14H22ClN3O2*H(1+)

4CNS(1-)*Cr(3+)*2C6H7N*C14H22ClN3O2*H(1+)

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water97%
metoclopramide
364-62-5

metoclopramide

Reinecke's salt

Reinecke's salt

4CNS(1-)*2H3N*Cr(3+)*C14H22ClN3O2*H(1+)

4CNS(1-)*2H3N*Cr(3+)*C14H22ClN3O2*H(1+)

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water96%
NH4(1+)*Cr(3+)*4NSC(1-)*2NH2CH2C6H5 = NH4[Cr(NCS)4(NH2CH2C6H5)2]

NH4(1+)*Cr(3+)*4NSC(1-)*2NH2CH2C6H5 = NH4[Cr(NCS)4(NH2CH2C6H5)2]

metoclopramide
364-62-5

metoclopramide

4CNS(1-)*Cr(3+)*2C7H9N*H(1+)*C14H22ClN3O2

4CNS(1-)*Cr(3+)*2C7H9N*H(1+)*C14H22ClN3O2

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water95%
metoclopramide
364-62-5

metoclopramide

2C6H12N4*4CNS(1-)*Cr(3+)*H4N(1+)

2C6H12N4*4CNS(1-)*Cr(3+)*H4N(1+)

2C6H12N4*4CNS(1-)*Cr(3+)*H(1+)*C14H22ClN3O2

2C6H12N4*4CNS(1-)*Cr(3+)*H(1+)*C14H22ClN3O2

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water93%
metoclopramide
364-62-5

metoclopramide

4CNS(1-)*Cr(3+)*H4N(1+)*2C6H5N3

4CNS(1-)*Cr(3+)*H4N(1+)*2C6H5N3

4CNS(1-)*Cr(3+)*H(1+)*2C6H5N3*C14H22ClN3O2

4CNS(1-)*Cr(3+)*H(1+)*2C6H5N3*C14H22ClN3O2

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water92%
metoclopramide
364-62-5

metoclopramide

4CNS(1-)*Cr(3+)*H4N(1+)*2C3H4N2

4CNS(1-)*Cr(3+)*H4N(1+)*2C3H4N2

4CNS(1-)*Cr(3+)*2C3H4N2*C14H22ClN3O2*H(1+)

4CNS(1-)*Cr(3+)*2C3H4N2*C14H22ClN3O2*H(1+)

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water91%
metoclopramide
364-62-5

metoclopramide

trifluoroacetic anhydride
407-25-0

trifluoroacetic anhydride

5-Chloro-N-(2-diethylamino-ethyl)-2-methoxy-4-(2,2,2-trifluoro-acetylamino)-benzamide
820965-31-9

5-Chloro-N-(2-diethylamino-ethyl)-2-methoxy-4-(2,2,2-trifluoro-acetylamino)-benzamide

Conditions
ConditionsYield
With triethylamine In chloroform86%
metoclopramide
364-62-5

metoclopramide

chloranil
118-75-2

chloranil

C14H22ClN3O2*C6Cl4O2
1569295-24-4

C14H22ClN3O2*C6Cl4O2

Conditions
ConditionsYield
In methanol at 20℃; for 0.25h; Thermodynamic data;82%
metoclopramide
364-62-5

metoclopramide

4-chlorophenyloxyacetyl chloride
4122-68-3

4-chlorophenyloxyacetyl chloride

cloxacepride
65569-29-1

cloxacepride

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;80.7%
metoclopramide
364-62-5

metoclopramide

2-cyclopentyl-2-hydroxy-2-phenylacetic acid
427-49-6

2-cyclopentyl-2-hydroxy-2-phenylacetic acid

2-chloro-4-{[2-(diethylamino)ethyl]carbamoyl}-5-methoxyanilinium-2-cyclopentyl-2-hydroxy-2-phenylacetate

2-chloro-4-{[2-(diethylamino)ethyl]carbamoyl}-5-methoxyanilinium-2-cyclopentyl-2-hydroxy-2-phenylacetate

Conditions
ConditionsYield
In acetone for 6h; Inert atmosphere; Reflux;80%
metoclopramide
364-62-5

metoclopramide

2-(4-fluorophenoxy)acetyl chloride
405-78-7

2-(4-fluorophenoxy)acetyl chloride

5-Chloro-N-(2-diethylamino-ethyl)-4-[2-(4-fluoro-phenoxy)-acetylamino]-2-methoxy-benzamide
85630-52-0

5-Chloro-N-(2-diethylamino-ethyl)-4-[2-(4-fluoro-phenoxy)-acetylamino]-2-methoxy-benzamide

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;78.3%
metoclopramide
364-62-5

metoclopramide

metoclopramide N-oxide
171367-22-9

metoclopramide N-oxide

Conditions
ConditionsYield
With dihydrogen peroxide Ambient temperature;77%
With 3-chloro-benzenecarboperoxoic acid In dichloromethane for 0.333333h; Ambient temperature;
Multi-step reaction with 3 steps
1: 86 percent / Et3N / CHCl3
2: 100 percent / m-chloroperbenzoic acid / CHCl3 / Ambient temperature
3: 100 percent / aq. Na2CO3 / methanol / Ambient temperature
View Scheme
metoclopramide
364-62-5

metoclopramide

urea
57-13-6

urea

4-Amino-5-cyano-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
65016-46-8

4-Amino-5-cyano-N-(2-diethylamino-ethyl)-2-methoxy-benzamide

Conditions
ConditionsYield
With nickel(II) acetylacetonate; potassium fluoride; phenylsilane; zinc; bis(2-diphenylphosphinoethyl)phenylphosphine In 1-methyl-pyrrolidin-2-one at 120℃; for 20h;76%
metoclopramide
364-62-5

metoclopramide

7,7',8,8'-tetracyanoquinodimethane
1518-16-7

7,7',8,8'-tetracyanoquinodimethane

C14H22ClN3O2*C12H4N4
1569257-76-6

C14H22ClN3O2*C12H4N4

Conditions
ConditionsYield
In methanol at 20℃; for 0.25h; Thermodynamic data;75%
metoclopramide
364-62-5

metoclopramide

2,3-dicyano-5,6-dichloro-p-benzoquinone
84-58-2

2,3-dicyano-5,6-dichloro-p-benzoquinone

C14H22ClN3O2*C8Cl2N2O2
1569257-75-5

C14H22ClN3O2*C8Cl2N2O2

Conditions
ConditionsYield
In methanol at 20℃; for 0.25h; Thermodynamic data;73%
metoclopramide
364-62-5

metoclopramide

(2-chloro-phenoxy)-acetyl chloride
20143-41-3

(2-chloro-phenoxy)-acetyl chloride

5-Chloro-4-[2-(2-chloro-phenoxy)-acetylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
65569-40-6

5-Chloro-4-[2-(2-chloro-phenoxy)-acetylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;72.4%
metoclopramide
364-62-5

metoclopramide

4-nitro-benzoic acid
62-23-7

4-nitro-benzoic acid

C14H22ClN3O2*C7H5NO4
1569257-78-8

C14H22ClN3O2*C7H5NO4

Conditions
ConditionsYield
In methanol at 20℃; for 0.25h; Thermodynamic data;71%
metoclopramide
364-62-5

metoclopramide

C14H21(2)HClN3O2

C14H21(2)HClN3O2

Conditions
ConditionsYield
With rhodium(III) chloride; water-d2 In N,N-dimethyl-formamide at 108℃;70%
metoclopramide
364-62-5

metoclopramide

2-(2,4-dichlorophenoxy)acetyl chloride
774-74-3

2-(2,4-dichlorophenoxy)acetyl chloride

5-Chloro-4-[2-(2,4-dichloro-phenoxy)-acetylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
85630-56-4

5-Chloro-4-[2-(2,4-dichloro-phenoxy)-acetylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;69.6%
metoclopramide
364-62-5

metoclopramide

2-(4-Chlorophenoxy)propionic acid chloride
4878-20-0

2-(4-Chlorophenoxy)propionic acid chloride

5-Chloro-4-[2-(4-chloro-phenoxy)-propionylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
65569-34-8

5-Chloro-4-[2-(4-chloro-phenoxy)-propionylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;68.3%
metoclopramide
364-62-5

metoclopramide

2,4,6-Trinitrophenol
88-89-1

2,4,6-Trinitrophenol

C14H22ClN3O2*C6H3N3O7
1569257-74-4

C14H22ClN3O2*C6H3N3O7

Conditions
ConditionsYield
In methanol at 20℃; for 0.25h; Thermodynamic data;66%
metoclopramide
364-62-5

metoclopramide

1,2-bis(4-formylphenoxy)ethane
34074-28-7

1,2-bis(4-formylphenoxy)ethane

C44H54Cl2N6O6

C44H54Cl2N6O6

Conditions
ConditionsYield
With acetic acid In ethanol Reflux;65%
meta-dinitrobenzene
99-65-0

meta-dinitrobenzene

metoclopramide
364-62-5

metoclopramide

C14H22ClN3O2*C6H4N2O4
1569257-77-7

C14H22ClN3O2*C6H4N2O4

Conditions
ConditionsYield
In methanol at 20℃; for 0.25h; Thermodynamic data;62%
metoclopramide
364-62-5

metoclopramide

p-methoxyphenoxyacetyl chloride
42082-29-1

p-methoxyphenoxyacetyl chloride

5-Chloro-N-(2-diethylamino-ethyl)-2-methoxy-4-[2-(4-methoxy-phenoxy)-acetylamino]-benzamide
85630-60-0

5-Chloro-N-(2-diethylamino-ethyl)-2-methoxy-4-[2-(4-methoxy-phenoxy)-acetylamino]-benzamide

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;60%
metoclopramide
364-62-5

metoclopramide

(2,3-dichlorophenoxy)acetyl chloride
85630-84-8

(2,3-dichlorophenoxy)acetyl chloride

5-Chloro-4-[2-(2,3-dichloro-phenoxy)-acetylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
85630-58-6

5-Chloro-4-[2-(2,3-dichloro-phenoxy)-acetylamino]-N-(2-diethylamino-ethyl)-2-methoxy-benzamide

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;59.7%
metoclopramide
364-62-5

metoclopramide

2-(4-iodophenoxy)acetyl chloride
20143-44-6

2-(4-iodophenoxy)acetyl chloride

5-Chloro-N-(2-diethylamino-ethyl)-4-[2-(4-iodo-phenoxy)-acetylamino]-2-methoxy-benzamide
65569-50-8

5-Chloro-N-(2-diethylamino-ethyl)-4-[2-(4-iodo-phenoxy)-acetylamino]-2-methoxy-benzamide

Conditions
ConditionsYield
With triethylamine In toluene for 6h; Heating;59.2%

364-62-5Relevant articles and documents

New findings in the synthesis of metoclopramide

Pakula,Butkiewicz,Trojanowska,Ruszczak

, p. 297 - 300 (1980)

-

COMPOUND, COMPOSITION AND USES THEREOF

-

Paragraph 00169, (2017/03/28)

The disclosures herein provide compounds of formula I, formula II, formula III, formula IV, formula V, formula VI and formula VII or its pharmaceutical acceptable compositions and salts, as well as polymorphs, enantiomers, stereoisomers, solvates, and hydrates thereof. These compositions or salts may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of stomach and esophageal problems or its associated complications.

Ex situ generation of stoichiometric and substoichiometric 12CO and 13CO and its efficient incorporation in palladium catalyzed aminocarbonylations

Hermange, Philippe,Lindhardt, Anders T.,Taaning, Rolf H.,Bjerglund, Klaus,Lupp, Daniel,Skrydstrup, Troels

, p. 6061 - 6071 (2011/06/19)

A new technique for the ex situ generation of carbon monoxide (CO) and its efficient incorporation in palladium catalyzed carbonylation reactions was achieved using a simple sealed two-chamber system. The ex situ generation of CO was derived by a palladium catalyzed decarbonylation of tertiary acid chlorides using a catalyst originating from Pd(dba)2 and P(tBu)3. Preliminary studies using pivaloyl chloride as the CO-precursor provided an alternative approach for the aminocarbonylation of 2-pyridyl tosylate derivatives using only 1.5 equiv of CO. Further design of the acid chloride CO-precursor led to the development of a new solid, stable, and easy to handle source of CO for chemical transformations. The synthesis of this CO-precursor also provided an entry point for the late installment of an isotopically carbon-labeled acid chloride for the subsequent release of gaseous [ 13C]CO. In combination with studies aimed toward application of CO as the limiting reagent, this method provided highly efficient palladium catalyzed aminocarbonylations with CO-incorporations up to 96%. The ex situ generated CO and the two-chamber system were tested in the synthesis of several compounds of pharmaceutical interest and all of them were labeled as their [ 13C]carbonyl counterparts in good to excellent yields based on limiting CO. Finally, palladium catalyzed decarbonylation at room temperature also allowed for a successful double carbonylation. This new protocol provides a facile and clean source of gaseous CO, which is safely handled and stored. Furthermore, since the CO is generated ex situ, excellent functional group tolerance is secured in the carbonylation chamber. Finally, CO is only generated and released in minute amounts, hence, eliminating the need for specialized equipment such as CO-detectors and equipment for running high pressure reactions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 364-62-5